Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-21-013384
Filing Date
2021-06-01
Accepted
2021-06-01 18:54:37
Documents
3
Period of Report
2021-05-26

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4282
2 ex24.htm EX-24 813
3 ex24_001.jpg GRAPHIC 280442
  Complete submission text file 0001493152-21-013384.txt   392997
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Issuer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 7389 Services-Business Services, NEC

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address
Barrage Khalil (Reporting) CIK: 0001666011 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12555 | Film No.: 21987038